Onions for Anti-Inflammatory

Research suggests that onions contain multiple bioactive compounds — including quercetin, kaempferol, fisetin, rutin, taxifolin, organosulfur compounds, and other flavonoids — that demonstrate anti-inflammatory properties across a range of laboratory and animal studies. The available evidence base consists predominantly of reviews and preclinical studies rather than human clinical trials, with findings consistently pointing in a supportive direction; one 1990 laboratory study found that sulfur-containing compounds from onions suppressed the migration of immune cells toward inflammation sites with potency comparable to or exceeding the drug prednisolone, while numerous reviews report that quercetin in particular inhibits histamine release, reduces pro-inflammatory cytokines, and modulates immune signaling pathways. Studies indicate that the broader Allium genus, which includes onions, has been documented to contain at least 260 bioactive compounds with anti-inflammatory activity confirmed across cell and animal models, though the evidence varies by species and compound. A notable limitation across this body of research is that many of the key compounds, especially quercetin, have poor bioavailability in the human body due to limited water solubility and first-pass metabolism, meaning that the effects observed in controlled laboratory settings may not reliably translate to the same outcomes in humans without further research into delivery and absorption.